Literature DB >> 15362205

Expression of matrix metalloproteinase 9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection.

Jian-Guo Tang1, Xuan Li, Ping Chen.   

Abstract

OBJECTIVE: To evaluate the expression of matrix metalloproteinase-9 (MMP9) in nasopharyngeal carcinoma and the association between MMP9 and Epstein-Barr virus infection.
METHODS: The MMP9 expression was studied by immunohistochemical analysis; and Epstein-Barr virus encoded small nuclear mRNA-1 (EBER-1) produced by in situ hybridization were examined in 41 nasopharyngeal carcinoma sections, and the relation between them, and the associations of MMP9 with clinical features were statistically analyzed.
RESULTS: Positive expression rate of MMP9 was 73.17%. The expression of MMP9 showed significant positive correlation with the expression of EBER-1 (gamma=0.483, P=0.001). There was significant association of MMP9 expression with lymph nodes metastasis and clinical stage (P<0.001), non-significant association with age, gender, pathological classification and T classification.
CONCLUSIONS: The highly pronounced expression of MMP9 is associated with cervical lymph nodes metastasis. Epstein-Barr virus can enhance NPC metastasis by up-regulating the expression of MMP9.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362205      PMCID: PMC1388738          DOI: 10.1631/jzus.2004.1304

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci        ISSN: 1009-3095


  13 in total

1.  Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.

Authors:  T Yoshizaki; H Sato; S Murono; J S Pagano; M Furukawa
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  [Study of the relation between MMP2, MMP9 and nasopharyngeal carcinoma].

Authors:  X Zhang; Y Guo; Q Ye; Z Yang; Z Dong
Journal:  Lin Chuang Er Bi Yan Hou Ke Za Zhi       Date:  1999-08

3.  Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.

Authors:  T Yoshizaki; T Horikawa; R Qing-Chun; N Wakisaka; H Takeshita; T S Sheen; S Y Lee; H Sato; M Furukawa
Journal:  Clin Cancer Res       Date:  2001-07       Impact factor: 12.531

Review 4.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

Authors:  L A Liotta
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

Review 5.  Biochemical interactions of tumor cells with the basement membrane.

Authors:  L A Liotta; C N Rao; U M Wewer
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

6.  Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of alpha(v) integrins.

Authors:  S Huang; D Stupack; A Liu; D Cheresh; G R Nemerow
Journal:  Oncogene       Date:  2000-04-06       Impact factor: 9.867

7.  Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.

Authors:  H Takeshita; T Yoshizaki; W E Miller; H Sato; M Furukawa; J S Pagano; N Raab-Traub
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.

Authors:  S Murono; H Inoue; T Tanabe; I Joab; T Yoshizaki; M Furukawa; J S Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

9.  The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model.

Authors:  Michael Lein; Klaus Jung; Bernhard Ortel; Carsten Stephan; Winfried Rothaug; Rolf Juchem; Manfred Johannsen; Serdar Deger; Dietmar Schnorr; Stefan Loening; Hans-Willi Krell
Journal:  Oncogene       Date:  2002-03-27       Impact factor: 9.867

10.  Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.

Authors:  Qingchun Ren; Hiroshi Sato; Shigeyuki Murono; Mitsuru Furukawa; Tomokazu Yoshizaki
Journal:  Laryngoscope       Date:  2004-05       Impact factor: 3.325

View more
  3 in total

1.  The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types.

Authors:  A S Abdulamir; R R Hafidh; N Abdulmuhaimen; F Abubakar; K A Abbas
Journal:  BMC Public Health       Date:  2008-12-05       Impact factor: 3.295

2.  Assessment and clinicopathological correlation of matrix metalloproteinase 9 expression in nasopharyngeal carcinoma.

Authors:  Ashok Kumar Das; Nizara Baishya; Anupam Sarma; Amal Chandra Kataki; Avdesh Kumar Rai; Chandi Ram Kalita
Journal:  J Carcinog       Date:  2019-05-09

3.  Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma.

Authors:  Hsin-Pai Li; Chen-Ching Peng; I-Che Chung; Mei-Yuan Huang; Shao-Tung Huang; Chia-Chun Chen; Kai-Ping Chang; Cheng-Lung Hsu; Yu-Sun Chang
Journal:  Oncotarget       Date:  2013-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.